Do Depressive Symptoms Mediate the Relationship Between Hopelessness and Diurnal Cortisol Rhythm?

International Journal of Behavioral Medicine

Volumn 22, Issue 2, 2015, Pages 251-257

  Pössel, Patrick ^a   Mitchell, Amanda M ^a   Sjögren, Elaine ^b   Kristenson, Margareta ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cross sectional study; Depressive symptoms; Diurnal cortisol rhythm; Hopelessness; Mediation model; Population based

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HOPE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AGED; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HOPE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LINEAR MODELS; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; RISK FACTORS; YOUNG ADULT;

EID: 84925511833     PISSN: 10705503     EISSN: 15327558     Source Type: Journal    
DOI: 10.1007/s12529-014-9422-6     Document Type: Article

References (42)

1. Pössel P, Adams E, Valentine JC. Depression as a risk factor for breast cancer: investigating methodological limitations in the literature. Cancer Causes Control. 2012;23:1223–9.
2. Leung YW, Flora DB, Gravely S, Irvine J, Carney RM, Grace SL. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom Med. 2012;74:786–801.
3. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.
4. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22:613–26.
5. Beck AT. Cognitive therapy and the emotional disorders. New York: International University Press; 1976.
6. Abramson LY, Metalsky GI, Alloy LB. Hopelessness depression: a theory-based subtype of depression. Psychol Rev. 1989;96:358–72.
7. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med. 1996;58:113–21.
8. Whipple MO, Lewis TT, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Powell LH, et al. Hopelessness, depressive symptoms, and carotid atherosclerosis in women: the study of women’s health across the nation (SWAN) heart study. Stroke. 2009;40:3166–72.
9. Pössel P, Mitchell AM, Ronkainen K, Kaplan GA, Kauhanen J, Valtonen M. Does depression predict the incidence of myocardial infarction independent of hopelessness? submitted.
10. McEwen B. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000;886:172–89.
11. Levine S, Ursin H. What is stress? In: Koob G, editor. Stress, neurobiology and neuroendocrinology. New York, NY, US: Marcel Decker; 1991. p. 1–21.
12. Sterling P, Eyer J. Allostasis: A new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook on life stress, cognition and health. Chichester, England: Wiley; 1988. p. 629–49.
13. Adam EK, Gunnar MR. Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology. 2001;26:189–208.
14. Dedert E, Lush E, Chagpar A, Dhabhar F, Segerstrom S, Spiegel D, et al. Stress, coping, and circadian disruption among women awaiting breast cancer surgery. Ann Behav Med. 2012;44:10–20.
15. Ong AD, Fuller-Rowell TE, Bonanno GA, Almeida DM. Spousal loss predicts alterations in diurnal cortisol activity through prospective changes in positive emotion. Health Psychol. 2011;30:220–7.
16. Doane LD, Adam EK. Loneliness and cortisol: momentary, day-to-day, and trait associations. Psychoneuroendocrinology. 2010;35:430–41.
17. Cohen S, Schwartz JE, Epel E, Kirschbaum C, Sidney S, Seeman T. Socioeconomic status, race, and diurnal cortisol decline in the coronary artery risk development in young adults (CARDIA) study. Psychosom Med. 2006;68:41–50.
18. Knight JM, Avery EF, Janssen I, Powell LH. Cortisol and depressive symptoms in a population-based cohort of midlife women. Psychosom Med. 2010;72:855–61.
19. Sjögren E, Leanderson P, Kristenson M. Diurnal saliva cortisol levels and relations to psychosocial factors in a population sample of middle-aged Swedish men and women. Int J Behav Med. 2006;13:193–200.
20. Bech P. Quality of life instruments in depression. Eur Psychiatry. 1997;12:194–8.
21. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychosom Med. 2003;33:351–6.
22. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord. 2001;66:159–64.
23. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension. 2000;35:561–7.
24. Pollitt RA, Daniel M, Kaufman JS, Lynch JW, Salonen JT, Kaplan GA. Mediation and modification of the association between hopelessness, hostility, and progression of carotid atherosclerosis. J Behav Med. 2005;28:53–64.
25. Dressendorfer R, Kirschbaum C, Rohde W, Stahl F, Strasburger G. Synthesis of a cortisol–biotin conjugate and elevation as a tracer of an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol. 1992;43:683–92.
26. Kristenson M, Garvin P, Lundberg U. The role of saliva cortisol measurement in health and disease. Introduction—why this book? In: Kristenson M, Garvin P, Lundberg U, editors. The role of saliva cortisol measurement in health and disease. Sharjah: Bentham; 2012. p. 3–16.
27. Jonsdottir IH, Halford C, Eek F. Mental health and saliva cortisol. In: Kristenson M, Garvin P, Lundberg U, editors. The role of saliva cortisol measurement in health and disease. Sharjah, UAE: Bentham; 2012. p. 129–66.
28. Broderick J, Arnold D, Kudielka B, Kirschbaum C. Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology. 2004;29:636–50.
29. Kudielka B, Broderick J, Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom Med. 2003;65:313–9.
30. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879–91.
31. Tofighi D, MacKinnon DP. RMediation: an R package for mediation analysis confidence intervals. Behav Res Methods. 2011;43:692–700.
32. Rohleder N, Marin TJ, Ma R, Miller GE. Biologic cost of caring for a cancer patient: dysregulation of pro and anti-inflammatory signaling pathways. J Clin Oncol. 2005;27:2909–15.
33. Hansem ÅM, Gunnarsson L-G, Harris A, Eller NH, Garvin P, Garde AH. Biological markers and salivary cortisol. In: Kristenson M, Garvin P, Lundberg U, editors. The role of saliva cortisol measurement in health and disease. Sharjah, UAE: Bentham; 2012. p. 87–115.
34. Chrousos GP, Gold PW. A healthy body in a healthy mind–and vice versa–the damaging power of “uncontrollable” stress. J Clin Endocrinol Metab. 1998;83:1842–5.
35. Fuller-Thomson E, Brennenstuhl S, Frank J. The association between childhood physical abuse and heart disease in adulthood: findings from a representative community sample. Child Abuse Negl. 2010;34:689–98.
36. Kubzansky LD, Sparrow D, Vokonas P, Kawachi I. Is the glass half empty or half full? A prospective study of optimism and coronary heart disease in the normative aging study. Psychosom Med. 2001;63:910–6.
37. Stamatakis KA, Lynch J, Everson SA, Raghunathan T, Salonen JT, Kaplan GA. Self-esteem and mortality: prospective evidence from a population-based study. Ann Epidemiol. 2004;14:58–65.
38. Pössel P, Knopf K. Bridging the gaps: an attempt to integrate three major cognitive depression models. Cogn Ther Res. 2011;35:342–58.
39. Sjögren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun. 2006;20:270–8.
40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington: American Psychiatric Association; 2013.
41. Do DP, Dowd JB, Ranjit N, House JS, Kaplan GA. Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med. 2010;72:613–9.
42. Cole DA, Maxwell SE. Testing mediational models with longitudinal data: questions and tips in the use of structural equation modeling. J Abnorm Psychol. 2003;112:558–77.